{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:18:33Z","timestamp":1782602313633,"version":"3.54.5"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9628-17","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T22:31:43Z","timestamp":1513809103000},"page":"1151-1154","source":"Crossref","is-referenced-by-count":20,"title":["Rituximab-induced Acute Thrombocytopenia in a Patient with Follicular Lymphoma: A Case Report and Review of the Literature"],"prefix":"10.2169","volume":"57","author":[{"given":"Yoshiyuki","family":"Omura","sequence":"first","affiliation":[{"name":"Department of Hematology, Mitsui Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shimazu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Mitsui Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Mitsui Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Engelhard M. Anti-CD20 antibody treatment of non-Hodgkin lymphomas. Clin Immunol 172: 101-104, 2016.","DOI":"10.1016\/j.clim.2016.08.011"},{"key":"2","unstructured":"2. McLaughlin P, Grillo-L\u00f3pez AJ, Link BK, et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 16: 2825-2833, 1998."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rigamonti C, Volta C, Colombi S, et al. Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion. Leukemia 15: 186-187, 2001.","DOI":"10.1038\/sj.leu.2401987"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shah C, Grethlein SJ. Case report of rituximab-induced thrombocytopenia. Am J Hematol. 75: 263, 2004.","DOI":"10.1002\/ajh.20028"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Pamuk GE, Donmez S, Turgut B, Demir M, Vural O. Rituximab-induced acute thrombocytopenia in a patient with prolymphocytic leukemia. Am J Hematol 78: 81, 2005.","DOI":"10.1002\/ajh.20218"},{"key":"6","unstructured":"6. Otrock ZK, Mahfouz RA, Oghlakian GO, Salem ZM, Bazarbachi A. Rituximab-induced acute thrombocytopenia: a report of two cases. Haematologica 90 (Suppl): ECR23, 2005."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Thachil J, Mukherje K, Woodcock B. Rituximab-induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia. Br J Haematol 135: 273-274, 2006.","DOI":"10.1111\/j.1365-2141.2006.06299.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rosado M, Chao H, Rose M. Severe acute thrombocytopenia following rituximab therapy. Leuk Lymphoma 48: 2239-2240, 2007.","DOI":"10.1080\/10428190701625099"},{"key":"9","unstructured":"9. Dhand S, Bahrain H. Rituximab-induced severe acute thrombocytopenia: a case report and review of literature. Cancer Invest 26: 913-915, 2008."},{"key":"10","unstructured":"10. Ram R, Bonstein L, Gafter-Gvili A, Ben-Bassat I, Shpilberg O, Raanani P. Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon. Am J Hematol 84: 247-250, 2009."},{"key":"11","unstructured":"11. Yi JH, Kim SJ, Ahn HK, Lee SJ, Chang MH, Kim WS. Rituximab-induced acute thrombocytopenia: a case report and review of the literature. Med Oncol 26: 45-48, 2009."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Parajuli R, Hire E, Shah BK. Rituximab-induced acute severe thrombocytopenia. Br J Haematol 149: 804, 2010.","DOI":"10.1111\/j.1365-2141.2010.08119.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kotsianidis I, Goutzouvelidis A, Anastasiades A, et al. Severe thrombocytopenia and fibrinolysis mimicking disseminated intravascular coagulation after rituximab infusion. Am J Hematol 85: 146, 2010.","DOI":"10.1002\/ajh.21597"},{"key":"14","unstructured":"14. Sadashiv SK, Rao R, Fazal S, Lister J. Rituximab-induced acute severe thrombocytopenia: a case series in patients with mantle cell lymphoma. Clin Lymphoma Myeloma Leuk 13: 602-605, 2013."},{"key":"15","unstructured":"15. El-Osta H, Nair B. Rituximab-induced acute thrombocytopenia: an underappreciated entity. Leuk Lymphoma 54: 2736-2737, 2013."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ureshino H, Nishioka A, Kojima K, et al. Rituximab-induced acute thrombocytopenia in high tumor burden follicular lymphoma. Intern Med 55: 2061-2064, 2016.","DOI":"10.2169\/internalmedicine.55.6140"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rafei H, Nassereddine S, Garcia IF. Disseminated intravascular coagulation-like reaction following rituximab infusion. BMJ Case Rep 8: 1-6, 2017.","DOI":"10.1136\/bcr-2016-218443"},{"key":"18","unstructured":"18. Larrar S, Guitton C, Willems M, Bader-Meunier B. Severe hematological side effects following Rituximab therapy in children. Haematologica 91 (8 Suppl): ECR36, 2006."},{"key":"19","unstructured":"19. Giezen TJ, Mantel-Teeuwisse AK, ten Berg MJ, et al. Rituximab-induced thrombocytopenia: a cohort study. Eur J Haematol 89: 256-266, 2012."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Qiao J, Al-Tamimi M, Baker RI, Andrews RK, Gardiner EE. The platelet Fc receptor, Fc\u03b3RIIa. Immunol Rev 268: 241-252, 2015.","DOI":"10.1111\/imr.12370"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Manshouri T, Do KA, Wang X, et al. Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance. Blood 101: 2507-2513, 2003.","DOI":"10.1182\/blood-2002-06-1639"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/8\/57_9628-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T10:22:17Z","timestamp":1570530137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/8\/57_9628-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9628-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}